Remove solutions participant-enrollment
article thumbnail

Grand Rounds February 23, 2024: Virtual Vigilance: Monitoring of Decentralized Clinical Trials (Adrian Hernandez, MD; Christopher J. Lindsell, PhD)

Rethinking Clinical Trials

There are 5 guiding principles for defining quality that should inform DCTs: Have we enrolled the right participants according to the protocol with adequate consent? Did participants receive the assigned treatment and did they stay on the treatment? What we often do not think about is verifying the identity of the participant.

article thumbnail

Including Patients with Borderline Personality Disorder in Clinical Trials

Worldwide Clinical Trials

By: Christine Moore, PhD, Vice President, Neuroscience, Scientific Solutions Patients with borderline personality disorder (BPD) face a heightened risk of substance abuse and suicide, as well as substantial delays in receiving treatment.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Enhancement, Efficiency, Equity, and Engagement: Four Trends Shaping Clinical Trials in 2024

ACRP blog

Eighty-five percent of trials fail to recruit enough patients, while 80% are delayed due to other factors like participant dropouts. Embracing technology for DCTs can significantly reduce the barriers leading to low enrollment and high dropout rates.

article thumbnail

Formosa, AimMax submit NDA to FDA for new pain therapy

Pharmaceutical Technology

The homogeneous nanosuspension looks like a solution that provides improved comfort to the eyes and helps drug penetrate well into ocular tissues. Both trials enrolled 151 subjects in a corneal endothelial cell safety substudy. Both trials enrolled 151 subjects in a corneal endothelial cell safety substudy.

Trials 130
article thumbnail

7 eCOA Solution Design Recommendations: Applied Insights from Trial Sites and CRAs 

VirTrial

The group developed seven concrete ideas for sponsors to consider incorporating into protocol design for participant visits, technology use, devices, and methods of back-up data collection: Thoroughly assess sites’ eCOA experience during site feasibility.

Trials 52
article thumbnail

Interview About Decentralized Oncology Trials with Devon Adams, Senior Analyst at the ACS CAN

XTalks

The goal of the ACS CAN is to “empower advocates across the country to make their voices heard and influence evidence-based public policy change as well as legislative and regulatory solutions that will reduce the cancer burden.”. Adams is a Senior Analyst for Policy and Legislative Support – Emerging Science at the ACS CAN.

Trials 98
article thumbnail

Rethinking trial engagement and recruitment starts with patient perspectives: patient survey insights

pharmaphorum

Step one was to better understand what would make possible participants’ desire to enrol and stay in trials. As will be discussed at the 2022 DPharm annual conference in Boston, IQVIA, a global clinical research organization, surveyed more than 6,400 participants across the U.S. Participants in the U.S. counterparts).

Trials 97